company? Let’s change
that.
BioSentinel develops innovative tools and reagents for the study of botulinum neurotoxin (BoNT).
Nexcyon is advancing veterinary medicine and improving the quality of life for companion animals around the world.
FluGen is a biopharmaceutical company specializing on the prevention and treatment of seasonal and pandemic influenza worldwide.
Lumiera Health Innovation offers innovative specialty pharmacy solutions, framed in the core principles of transparency and stewardship.
CLG -Multi-species Stem Cell Characterization Services and Products & Custom Assay Development
Centrose is a biotechnology company engaged in the development and commercialization of therapeutics targeting disease related cells.
PharmaSeek mission is to bring efficiencies to the clinical research industry by providing administrative services to sites.
A devision of ATTWILL Vascular Technologies, Attwill Medical Solutions purchased the assets of Anteco Pharma facility In 2017. Attwill Medical Solutions specializes in the lyophilization and related processing of pharmaceutical intermediates, medical devices and specialty food and nutritional ingredients. ATTWILL operates a fully integrated commercialization business within a 36,500 square foot facility that includes R&D laboratories, piloting facilities and seven ISO 7 cleanrooms for manufacturing. Our ISO 13485 2016 manufacturing includes six freeze dryers that are used in the processing of ATTWILL products and in contract manufacturing of products that include pharmaceuticals, drug ingredients, medical devices, and nutraceuticals
Stem Pharm's synthetic biomaterials support the optimization of cell expansion
A leading applied technology services company, we innovate to deliver service excellence and successful outcomes across sales, delivery and development. With our strategy to be agile, nimble and customer-centric, we anticipate the future of applied technology and predict tomorrow’s trends to keep our clients at the summit in an ever-changing marketplace. Leading with architecture and design, our next-gen solutions enable enterprises to accelerate on their digital transformation journey.
We provide phenotypic compound screening services for first-in-class drug discovery and drug repositioning
PPD is now part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and PPD are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We now offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.
Invenra is focused on developing the next generation of best-in-class biologics, with an emphasis on multispecific antibodies and their derivatives. Invenra's proprietary technologies combine our highly developable B-Body™ bispecific platform with high throughput functional screening, enabling the optimization of unprecedented numbers of bispecific antibodies in phenotypic assays. Invenra has a pipeline of immuno-oncology bispecific antibodies that are currently in preclinical studies.
Work Your Passion. Live Your Purpose.